Medicure (CVE:MPH) Share Price Passes Below 50-Day Moving Average – Here’s Why

Medicure Inc. (CVE:MPH)’s stock price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$1.44 and traded as low as C$1.38. Medicure shares last traded at C$2.59, with a volume of 3,114 shares trading hands.

Medicure Stock Performance

The stock has a market capitalization of C$25.99 million, a PE ratio of -3.46 and a beta of 0.93. The company has a debt-to-equity ratio of 6.02, a quick ratio of 1.28 and a current ratio of 0.97. The firm has a 50 day moving average of C$1.49 and a 200-day moving average of C$1.26.

About Medicure

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.